Mainz Biomed B.V.
MYNZ | NASDAQ
$3.59
+$0.03 (+0.84%)
At close: May 22, 2026, 12:35 PM ET
Market Data
Market Cap $14.69M
Enterprise Value $1.32M
Beta 0.32
Average Volume 554.37K
Shares Outstanding (Diluted) 17.85M
Shares Change YoY 3094.89%
Institutional Ownership N/A
Exchange NASDAQ
ISIN NL0015000LC2
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD 209.5%
Price Change 1Y 124.4%
Price Change 3Y -96.1%
Price Change 5Y -99.1%
1M CAGR (ann.) -36.3%
1Y CAGR (ann.) -83.7%
5Y CAGR (ann.) N/A
All-Time CAGR -76.3%
Valuation
PE Ratio -3.42
Forward PE N/A
PEG Ratio -0.02
Forward PEG 0.04
PS Ratio 58.68
Forward PS 1.60
PB Ratio 0.72
P/FCF Ratio -1.46
P/Adj. FCF Ratio -0.87
P/OCF Ratio -6.53
EV/Sales 5.25
EV/EBIT -0.24
EV/EBITDA -0.09
EV/FCF -0.13
Earnings Yield -29.3%
FCF Yield -68.3%
Adj. FCF Yield -114.3%
Financial Health
Net Cash $13.38M
Total Debt $0
Cash & Short-Term Investments $13.38M
Total Assets $23.37M
Current Ratio 5.56
Quick Ratio 5.56
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 683.39
Altman Z-Score -4.37
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 33.7%
Operating Profit Margin -6109.7%
EBITDA Margin -6002.7%
Net Profit Margin -7542.2%
FCF Margin -4008.0%
Adj. FCF Margin -6708.6%
SBC / Revenue 2700.6%
SBC Impact (per share) -67.4%
Returns
Return on Assets -80.8%
Return on Equity -179.8%
Return on Invested Capital -75.1%
Return on Capital Employed -75.1%
Return on Tangible Assets -112.2%
Historical Growth (CAGR)
Revenue CAGR 3Y -7.6%
Revenue CAGR 5Y 1.7%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 5.3%
EPS CAGR 5Y -37.3%
EPS CAGR 10Y N/A
FCF CAGR 3Y -1.0%
FCF CAGR 5Y -12.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 44.4%
Revenue Growth Next 3Y 566.2%
Earnings Date Apr 14, 2026
EPS Estimate (next Q) -$1.01
EPS Growth Est (next Q) -77.0%
Revenue Est (next Q) $670K
Revenue Growth Est (next Q) 123.3%
Cash Flow
Operating Cash Flow $-9.9M
Free Cash Flow $-10.03M
Adj. Free Cash Flow $-16.8M
FCF Per Share -$0.56
OCF Per Share -$0.55
OCF/S Ratio -3953.1%
Income Statement
Revenue $250.36K
Gross Profit $84.41K
Operating Income $-15.3M
EBITDA $-15.03M
Net Income $-18.88M
EPS (Diluted) -$1.05
Revenue / Employee $13.18K
Profit / Employee $-993.84K
Employees 19
Add to Watchlist
Select watchlists to add or remove MYNZ